murine MAb anti-human TFPI Kunitz domain 1
Description
The monoclonal antibody ADG4903 (clone 2H8) is a murine monoclonal antibody, subclass IgG1 recognizing human Tissue factor pathway inhibitor (TFPI). Mice were immunized with purified native human tissue factor pathway inhibitor (TFPI, 38 kDa) from cultured HEP G-2 cells.(1) The epitope specificity of this antibody is aa 22-87, within Kunitz domain I of human TFPI which is involved in the TF/fVIIa interaction. This antibody neutralizes human TFPI, see Applications, below.
Presentation
Screw capped vial containing 100 µg of purified antibody in PBS pH 7.4, 0.01 % ProClin. The IgG concentration is 1 mg/ml. Spin the vial briefly before opening.
Storage and Stability
Store the antibody at 2°-8°C. For long-term storage the antibody should be aliquoted and stored at -20°C or colder. It is recommended to avoid freeze-thaw cycles.
Applications
Western Blot Analysis: at 5 μg/mL the antibody will detect 50 ng/mL of human TFPI under nonreducing conditions only. (2)
Immunohistochemistry: the antibody is suitable for staining of human TFPI in formalin-fixed tissue sections. (3, 4)
Flow cytometry: the antibody was used for staining of cells for flow cytometric analysis. (4)
Neutralization of human TFPI inhibition (complexed with human FXa, product no. 526): at 5 μg/mL the antibody neutralizes TFPI at 5 ng/mL
The antibody prevents the inhibition of the TF-FVIIa function. (5)
Category: Research use only
Type: Antibody
Product Availability: Worldwide
Manufacturer: ImmBioMed GmbH & Co KG, Germany
For more information please click the .pdf icon below.
murine MAb anti-human TFPI Kunitz domain 1, clone 2H8
Cat.No. ADG4903
Artikelnr.: 938957
Einheit: 100 µg
Code: ADG4903
Hersteller: ImmBioMed GmbH & Co. KG
References
- Isolation of the tissue factor inhibitor produced by HepG2 hepatoma cells. Broze GJ Jr and Miletich JP. Proc Natl Acad Sci.1987 Apr;84(7):1886-1890.
- Tissue factor pathway inhibitor is expressed by human monocyte-derived macrophages: relationship to tissue factor induction by cholesterol and oxidized LDL. Petit L et al., Arterioscler Thromb Vasc Biol. 1999 Feb;19(2): 309-15.
- Local gene transfer of tissue factor pathway inhibitor regulates intimal hyperplasia in atherosclerotic arteries. Zoldhelyi P. et al., Proc Natl Acad Sci. 2001 Mar 27;98(7):4078-4083.
- The role of TFPI in regulation of TF-induced thrombogenicity on the surface of human monocytes. Basavaraj MG et al., Thromb Res. 2010 Nov;126(5):418-25.
- Ligand-induced protease receptor translocation into caveolae: a mechanism for regulating cell surface proteolysis of the tissue factor-dependent coagulation pathway. Sevinsky JR et al., J Cell Biol. 1996 Apr;133(2):293-304.